文献
J-GLOBAL ID:202202273253274960
整理番号:22A1070910
SARS-CoV-2を中和するカシリビマブ-イムデビマブ:注射後の臨床イベントとそれらの危険因子
Casirivimab-imdevimab neutralizing SARS-CoV-2: post-infusion clinical events and their risk factors
著者 (8件):
Junichi Yoshida,
(Infection Control Committee, Shimonoseki City Hospital, Shimonoseki, Japan)
,
Kenichiro Shiraishi,
(Department of Medicine and Biosystemic Science, Kyushu University Faculty of Medicine, Fukuoka, Japan)
,
Tetsuro Tamura,
(Infection Control Committee, Shimonoseki City Hospital, Shimonoseki, Japan)
,
Kazuhiro Otani,
(Infection Control Committee, Shimonoseki City Hospital, Shimonoseki, Japan)
,
Tetsuya Kikuchi,
(Infection Control Committee, Shimonoseki City Hospital, Shimonoseki, Japan)
,
Akiko Mataga,
(Infection Control Committee, Shimonoseki City Hospital, Shimonoseki, Japan)
,
Takako Ueno,
(Infection Control Committee, Shimonoseki City Hospital, Shimonoseki, Japan)
,
Masao Tanaka,
(Infection Control Committee, Shimonoseki City Hospital, Shimonoseki, Japan)
資料名:
Journal of Pharmaceutical Health Care and Sciences (Web)
(Journal of Pharmaceutical Health Care and Sciences (Web))
巻:
8
号:
1
ページ:
1-5
発行年:
2022年
JST資料番号:
U1100A
ISSN:
2055-0294
資料種別:
逐次刊行物 (A)
記事区分:
短報
発行国:
イギリス (GBR)
言語:
英語 (EN)